Endocrine and metabolic diseases. Pituitary diseases.
作者信息
Strong J A
出版信息
Br Med J. 1976 Mar 13;1(6010):640-2. doi: 10.1136/bmj.1.6010.640.
Abstract
摘要
相似文献
1
Endocrine and metabolic diseases. Pituitary diseases.内分泌与代谢疾病。垂体疾病。
Br Med J. 1976 Mar 13;1(6010):640-2. doi: 10.1136/bmj.1.6010.640.
2
Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSH.2014年垂体肿瘤的治疗：生长激素、促肾上腺皮质激素和促甲状腺激素分泌性腺瘤的治疗进展
Nat Rev Endocrinol. 2015 Feb;11(2):73-4. doi: 10.1038/nrendo.2014.227. Epub 2014 Dec 23.
3
Bromocriptine and pituitary disorders.溴隐亭与垂体疾病
Ann Intern Med. 1979 Jun;90(6):980-2. doi: 10.7326/0003-4819-90-6-980.
4
Diagnosis and management of hypopituitarism.垂体功能减退症的诊断与管理
J R Coll Physicians Lond. 1972 Oct;7(1):19-33.
5
Clinical pituitary disorders.临床垂体疾病
Bull Los Angeles Neurol Soc. 1977;42(3-4):81-91.
6
Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients.促甲状腺激素释放激素在垂体和下丘脑疾病中的诊断价值。对100例患者促甲状腺激素和催乳素分泌的评估。
Ann Intern Med. 1974 Dec;81(6):751-7. doi: 10.7326/0003-4819-81-6-751.
7
Pituitary function.垂体功能。
N Engl J Med. 1971 Sep 9;285(11):617-9. doi: 10.1056/NEJM197109092851107.
8
Thyrotropic pituitary adenoma with plurihormonal immunoreactivity.具有多激素免疫反应性的促甲状腺素垂体腺瘤。
Neurol India. 2017 Sep-Oct;65(5):1162-1164. doi: 10.4103/neuroindia.NI_577_16.
9
Pituitary disease.垂体疾病
Br Med J. 1970 Nov 21;4(5733):447-8.
10
IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction.胰岛素样生长因子-I（IGF-I）水平反映了垂体功能障碍成年患者的垂体功能减退严重程度。
Pituitary. 2016 Aug;19(4):399-406. doi: 10.1007/s11102-016-0718-1.
Zotero 插件